GxP Best Practices For Safer, Smarter, Faster Clinical Research
By Lenore McKnight, Director, Product Marketing

Within the realm of clinical research, GxP represents a comprehensive framework of quality standards and regulations meticulously crafted to uphold the safety, effectiveness, and ethical soundness of pharmaceuticals, medical devices, and clinical trial processes. The term GxP represents a general abbreviation for “good practice” guidelines and regulations, with the “x” acting as a placeholder relevant to a particular field. Traditionally, based on the clinical research lifecycle, this includes:
- Good clinical practice (GCP)
- Good laboratory practice (GLP)
- Good manufacturing practice (GMP)
- Good pharmacovigilance practice (GPvP)
- Good distribution practice (GDP)
This blog delves into fundamental GxP principles, essential regulatory aspects, and underscores the critical role GxP plays in ensuring the achievement of prosperous and ethical clinical trials.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.